What is the official website of Novartis Deutschland ?

The official website of Novartis Deutschland is http://www.novartis.de.

What is Novartis Deutschland's cybersecurity risk score?

Novartis Deutschland has an AI-generated cybersecurity risk score of 756 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Novartis Deutschland experienced?

According to Rankiteo, Novartis Deutschland currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Novartis Deutschland been affected by any supply chain cyber incidents ?

According to Rankiteo, Novartis Deutschland has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Novartis Deutschland have SOC 2 Type 1 certification ?

According to Rankiteo, Novartis Deutschland is not certified under SOC 2 Type 1.

Does Novartis Deutschland have SOC 2 Type 2 certification ?

According to Rankiteo, Novartis Deutschland does not hold a SOC 2 Type 2 certification.

Does Novartis Deutschland comply with GDPR ?

According to Rankiteo, Novartis Deutschland is not listed as GDPR compliant.

Does Novartis Deutschland have PCI DSS certification ?

According to Rankiteo, Novartis Deutschland does not currently maintain PCI DSS compliance.

Does Novartis Deutschland comply with HIPAA ?

According to Rankiteo, Novartis Deutschland is not compliant with HIPAA regulations.

Does Novartis Deutschland have ISO 27001 certification ?

According to Rankiteo,Novartis Deutschland is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Novartis Deutschland operate in ?

Novartis Deutschland operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Novartis Deutschland have ?

Novartis Deutschland employs approximately 442 people worldwide.

Does Novartis Deutschland own any subsidiaries ?

Novartis Deutschland presently has no subsidiaries across any sectors.

How many LinkedIn followers does Novartis Deutschland have ?

Novartis Deutschland's official LinkedIn profile has approximately 31,002 followers.

What is the NAICS classification code for Novartis Deutschland ?

Novartis Deutschland is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Novartis Deutschland have a Crunchbase profile ?

No, Novartis Deutschland does not have a profile on Crunchbase.

Does Novartis Deutschland have a LinkedIn profile ?

Yes, Novartis Deutschland maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/novartis-deutschland.

How many cybersecurity incidents has Novartis Deutschland experienced ?

As of October 13, 2026, Rankiteo reports that Novartis Deutschland has experienced 2 cybersecurity incidents.

How many peer or competitor companies does Novartis Deutschland have ?

Novartis Deutschland has an estimated 5,775 peer or competitor companies worldwide.

What types of cybersecurity incidents has Novartis Deutschland faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Cyber Attack and Breach.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Novartis Deutschland

Boost Score +25 with badge (5 left)

756

/1000

Fair

781

/1000

Fair

Novartis Deutschland Vendor Cyber Rating & Cyber Score

novartis.de

Add Your Compliance Badge

Novartis ist ein führendes Pharmaunternehmen in Deutschland mit ca. 2.600 Mitarbeitenden an verschiedenen Standorten und mehr als 70.000 Mitarbeitenden weltweit. Wir sind angetrieben davon, Medizin neu zu denken, um das Leben von Menschen zu verbessern. Wir nutzen Wissen, Kreativität und Engagement unserer Mitarbeitenden, die Chancen wissenschaftlicher Forschung sowie digitale Technologien, um wegweisende Therapien in verschiedenen Gesundheitsbereichen zu entwickeln. Wir wollen die besten Talente an uns binden und bieten ihnen den Arbeitsplatz und die Entwicklungsmöglichkeiten eines internationalen Marktführers. Als innovatives Unternehmen ist Novartis ein attraktiver Arbeitgeber für Absolventinnen und Absolventen unterschiedlichster

Novartis Deutschland

Novartis Deutschland CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Novartis

Breach

2/2026

NOV1774449180

Novartis Deutschlan...

Cyber Attack

100

06/2022

NOV21267722

Loading…

A.I.

Novartis Deutschland Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Novartis Deutschland

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Novartis Deutschland in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Novartis Deutschland in 2026.

Incident Types Novartis Deutschland vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Novartis Deutschland in 2026.

Incident History - Novartis Deutschland (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Novartis Deutschland Subsidiaries

Novartis Deutschland

Pharmaceutical Manufacturing

Website: http://www.novartis.de

Company Size: 442

NovartisPharmaceutical Manufacturing

Novartis IndiaPharmaceutical Manufacturing

Novartis BrasilPharmaceutical Manufacturing

Novartis MéxicoPharmaceutical Manufacturing

Novartis CanadaPharmaceutical Manufacturing

Novartis Gene TherapiesBiotechnology Research

Novartis SlovakiaPharmaceutical Manufacturing

Novartis ItaliaPharmaceutical Manufacturing

Novartis Gulf | نوفارتس الخليجPharmaceutical Manufacturing

Novartis SingaporePharmaceutical Manufacturing

Novartis DanmarkPharmaceutical Manufacturing

Novartis Ireland Pharmaceutical Manufacturing

Novartis EspañaPharmaceutical Manufacturing

Novartis SverigePharmaceutical Manufacturing

Novartis SlovakiaPharmaceutical Manufacturing

Novartis, Australia & New ZealandPharmaceutical Manufacturing

Novartis SciencePharmaceutical Manufacturing

Novartis SlovakiaPharmaceutical Manufacturing

Novartis RomâniaPharmaceutical Manufacturing

Novartis SerbiaPharmaceutical Manufacturing

Novartis MagyarországPharmaceutical Manufacturing

Novartis ColombiaPharmaceutical Manufacturing

Novartis Hong KongPharmaceutical Manufacturing

Novartis NorgePharmaceutical Manufacturing

Novartis FinlandPharmaceutical Manufacturing

Novartis PortugalPharmaceutical Manufacturing

Novartis US MedicalPharmaceutical Manufacturing

Novartis SlovakiaPharmaceutical Manufacturing

Novartis BeluxPharmaceutical Manufacturing

Novartis USPharmaceutical Manufacturing

Novartis SlovakiaPharmaceutical Manufacturing

Novartis NederlandPharmaceutical Manufacturing

Novartis Nederland - NeurologieGeneesmiddelenproductie

Novartis Nederland - OncologieGeneesmiddelenproductie

Novartis Nederland - ReumatologieGeneesmiddelenproductie

Novartis Nederland - HematologieGeneesmiddelenproductie

Novartis Nederland - DermatologieGeneesmiddelenproductie

Novartis Nederland - Cardiovascular, Renal & Metabolism Geneesmiddelenproductie

Novartis MedicalPharmaceutical Manufacturing

Novartis SlovakiaPharmaceutical Manufacturing

Novartis IsraelPharmaceutical Manufacturing

Novartis ArgentinaPharmaceutical Manufacturing

Novartis in SloveniaPharmaceutical Manufacturing

Loading…

Novartis Deutschland Similar Companies

Grifols

cb linktr.ee

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases. With a workforce of over 23,000 employees in more than 30 countries and regions, we are committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. People are at the heart of what we do, and we strive to create an inclusive, diverse, fair and equal society. Maintaining and promoting a workforce that reflects this reality leads to enhanced professional relationships and helps us to give our best to patients, donors and customers. In 2024, Grifols was named one of TIME’s ‘World’s Best Companies’ for the second year in a row, reaffirming our commitment to excellence. We were also recognized by Forbes as one of the "Best Employers for Women 2023," reflecting our dedication to fostering an inclusive and supportive workplace for all. To maintain a positive community and overall respectful communication, please keep our community guidelines in mind.

Zydus Group

zyduslife.com

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worldwide and is driven by its mission to unlock new possibilities in life-sciences through quality healthcare solutions that impact lives. The group aspires to transform lives through pathbreaking discoveries.

Sandoz

sandoz.com

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Read our community engagement guidelines: http://bit.ly/4ofoggc

EMS

cb ems.com.br

Fundada há mais de 60 anos e com capital 100% nacional, a EMS é a líder do mercado farmacêutico brasileiro há 19 anos consecutivos, pertencente ao Grupo NC, um dos maiores conglomerados brasileiros. A empresa ocupa também a liderança no segmento de genéricos desde 2013 (IQVIA 2019) e está entre os maiores laboratórios em preferência prescritiva no Brasil. Tem forte presença em PDVs de todo o país e atuação nas áreas de Prescrição Médica, Genéricos, Marcas, OTC e Hospitalar, fabricando medicamentos para praticamente todas as especialidades da Medicina. Possui fábricas em Hortolândia (SP), Manaus (AM), Brasília (DF) e Jaguariúna (SP). A EMS apoia ações de responsabilidade social dentro e fora do Brasil. Em 2017, por exemplo, o laboratório fechou parceria com a Organização Mundial da Saúde (OMS) para doar 100% do medicamento para erradicar, nos próximos anos, em todo o planeta, a bouba, doença negligenciada. A EMS é a única farmacêutica no mundo a ter abraçado essa causa. O Centro de Pesquisa & Desenvolvimento da EMS no Brasil é o mais moderno da América Latina. Na Itália, a EMS tem o laboratório de pesquisas MonteResearch. O foco de atuação do laboratório é a inovação nas seguintes frentes: inovação incremental; genéricos de alta complexidade; medicamentos biotecnológicos, por meio da empresa Bionovis; e inovação disruptiva, por meio da Brace Pharma, empresa da EMS instalada em 2013 nos Estados Unidos. Ainda, nos EUA, por meio de sua controlada Vero Biotech, localizada em Atlanta, Geórgia, a EMS, recentemente, obteve a aprovação de seu primeiro produto revolucionário submetido à FDA (Food and Drug Administration), posicionando o laboratório como uma empresa de inovação no mercado global. Com aportes frequentes em infraestrutura fabril e em pesquisa de ponta para desenvolver produtos inovadores, eficazes e seguros, a EMS, que já exporta para mais de 40 países, está preparada para continuar cuidando das pessoas que querem viver cada vez mais e melhor.

Takeda

cb takeda.com

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

Teva Pharmaceuticals

tevapharm.com

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

MACLEODS PHARMACEUTICALS LTD.

macleodspharma.com

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.

Johnson & Johnson Innovative Medicine

jnj.com

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently address the most complex diseases of our time and develop the potential medicines of tomorrow. We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way. https://bit.ly/3reuMvK

Zoetis

zoetis.com

The world’s leading animal health company. We’ve been innovating ways to predict, prevent, detect, and treat animal illness for over 70 years, and we continue to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers. Our leading portfolio and pipeline makes a difference in over 100 countries. Community Guidelines: This page is intended to share how Zoetis is advancing care for animals. We aspire to create a supportive community, but there are guidelines to which posts and comments on this page must adhere. If your post references a side effect related to any Zoetis product, we may contact you for more information. To monitor the safety of Zoetis products, we advise you to call our Veterinary Medical Information and Product Support Team at 1-888-963-8471; Support Team is available Mon-Fri 9am to 6:30pm ET. We reserve the right to remove any post/comment that violates LinkedIn Guidelines. As a last resort, we reserve the right to block users that demonstrate a repeated pattern of violating LinkedIn’s spirit of constructive, professional discourse. We respectfully request that you refrain from posting comments including: Unsolicited and/or unverified medical advice Vulgarity and/or profanity Discriminatory and/or derogatory comments, hate speech Politics and religion Personal attacks and/or threats Promotion of illegal activity Copyright/trademark infringements Topics that may be considered spam/advertising Our regular business hours are Mon-Fri 9am to 5pm ET. Zoetis does not endorse and is not responsible for information and opinions shared by community members. The information shared is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. Testimonials represent individual experience only and the experiences and opinions of community members may be unique to the speaker. Terms of Use: https://www.zoetis.com/terms-of-use

Loading…

NEWS

Novartis Deutschland CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

November 08, 2023 08:00 AM

Top 10 CISOs in EMEA

We consider some of the leading CISOs within the EMEA region who are committed to developing and implementing security policies to protect...

Read Article

September 26, 2011 07:00 AM

Novartis Vaccine Manufacturing Facility

Novartis has begun production at its new vaccine manufacturing facility in Marburg, Germany in April 2011. The plant produces rabies and...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-93892

SUMMARY

IBM TRIRIGA Application Platform 5.0.0 through 5.0.8 could allow a remote authenticated attacker to obtain sensitive information due to exposure of session tokens in the HTML response.

Published

Date2026-10-12

Updated

Date2026-10-12

RISK INFORMATION (Score: 8.1)

cvss3

Base Score: 8.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N

Impact Score

5.2

Exploitability

2.8

REFERENCES

https://www.ibm.com/support/pages/node/7292035

CVE-2026-93891

SUMMARY

IBM TRIRIGA Application Platform 5.0.0 through 5.0.8 could allow a remote authenticated attacker to obtain sensitive information due to an XML external entity (XXE) injection flaw.

Published

Date2026-10-12

Updated

Date2026-10-12

RISK INFORMATION (Score: 7.6)

cvss3

Base Score: 7.6

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:C/C:H/I:N/A:L

Impact Score

4.7

Exploitability

2.3

REFERENCES

https://www.ibm.com/support/pages/node/7292036

CVE-2026-92832

SUMMARY

IBM Aspera Enterprise WebApps 1.0.0 through 1.0.6 could allow a local attacker to obtain sensitive information due to cleartext transmission of sensitive information.

Published

Date2026-10-12

Updated

Date2026-10-12

RISK INFORMATION (Score: 5.1)

cvss3

Base Score: 5.1

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N

Impact Score

2.5

Exploitability

2.5

REFERENCES

https://www.ibm.com/support/pages/node/7291755

CVE-2026-85457

SUMMARY

IBM Planning Analytics 2.0, and 2.1 could allow a remote authenticated attacker to execute arbitrary code due to a stack-based buffer overflow.

Published

Date2026-10-12

Updated

Date2026-10-12

RISK INFORMATION (Score: 8.1)

cvss3

Base Score: 8.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N

Impact Score

5.2

Exploitability

2.8

REFERENCES

https://www.ibm.com/support/pages/node/7291604

CVE-2026-84418

SUMMARY

IBM DataStage on Cloud Pak for Data 5.4.0.0 can allow a man-in-the-middle attacker to present a forged TLS certificate, intercept the connection, and capture the IAM bearer Authorization header automatically attached by the session adapter. The captured token grants full platform-scope tenant API access, enabling the attacker to read and manipulate the victim's DataStage projects, flows, assets, and pipeline definitions. This is client-side SDK code running on the user's own machine, so exploitation requires an external network interceptor rather than a co-tenant in the shared cluster.

Published

Date2026-10-12

Updated

Date2026-10-12

RISK INFORMATION (Score: 7.4)

cvss3

Base Score: 7.4

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:N

Impact Score

5.2

Exploitability

2.2

REFERENCES

https://www.ibm.com/support/pages/node/7288649

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Novartis Deutschland Vendor Cyber Rating & Cyber Score

Novartis Deutschland A.I CyberSecurity Scoring

Novartis Deutschland CyberSecurity News & History

Novartis Deutschland Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Novartis Deutschland

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Novartis Deutschland vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Novartis Deutschland (X = Date, Y = Severity)

Novartis Deutschland Subsidiaries

Novartis Deutschland

Novartis Deutschland Similar Companies

Grifols

Zydus Group

Sandoz

EMS

Takeda

Teva Pharmaceuticals

MACLEODS PHARMACEUTICALS LTD.

Johnson & Johnson Innovative Medicine

Zoetis

Novartis Deutschland CyberSecurity News

Top 10 CISOs in EMEA

Novartis Vaccine Manufacturing Facility

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Novartis Deutschland CyberSecurity News & History

Novartis Deutschland Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Novartis Deutschland

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Novartis Deutschland vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Novartis Deutschland (X = Date, Y = Severity)

Novartis Deutschland Subsidiaries

Novartis Deutschland

Novartis Deutschland Similar Companies

Grifols

Zydus Group

Sandoz

EMS

Takeda

Teva Pharmaceuticals

MACLEODS PHARMACEUTICALS LTD.

Johnson & Johnson Innovative Medicine

Zoetis

Novartis Deutschland CyberSecurity News

Top 10 CISOs in EMEA

Novartis Vaccine Manufacturing Facility

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo